Percutaneous treatment of coronary bifurcations: Lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y study

Journal of Interventional Cardiology

Volumn 20, Issue 2, 2007, Pages 114-121

  Ribichini, Flavio ^a   Ferrero, Valeria ^a   Rognoni, Andrea ^b   Marino, Paolo ^b   Brunelleschi, Sandra ^b   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISONE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHERECTOMY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY STENT; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPRESS Y STUDY; MALE; METAL IMPLANTATION; METHODOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; SYSTEMIC THERAPY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTI-INFLAMMATORY AGENTS; ATHERECTOMY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY RESTENOSIS; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; STENTS; TIME FACTORS;

EID: 33947397146     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00250.x     Document Type: Article

References (27)

1. Al Suwaidi J, Yeh W, Cohen HA, et al. Immediate and oneyear outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 2001;87:1139-1144.
2. Moses JW, Leon MB, Popma JJ, et al. for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary arteries. N Engl J Med 2003;349:1315-1323.
3. Stone GW, Ellis SG, Cox DA, et al. for the TAXUS-IV Investigators. A Polymer-based, Paclitaxel-eluting stent in patients with coronary artery disease.NEngl JMed 2004;350:221-231.
4. Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of the randomized clinical trials of drug-eluting stents. Lancet 2004;364:583-591.
5. Morice MC, Colombo A, Meier B, et al. Sirolimus vs Paclitaxeleluting stents in de novo coronary artery lesions. The reality trial: A randomized controlled trial. JAMA2006;295:895-904.
6. Colombo A, Moses J, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-1249.
7. Pan M, Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus a complex strategy. Am Heart J 2004;148:857-864.
8. Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions. The Nordic Bifurcation Study. Circulation 2006;114:1955-1961.
9. Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique. Importance of final kissing balloon post-dilatation. J Am Coll Cardiol 2005;46:613-620.
10. Ge L, Iakovou I, Cosgrave J, et al. Treatment of bifurcation lesions with two stents: One year angiographic and clinical follow-up of crush versus T stenting. Heart 2006;92:371-376.
11. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol 2005;46:1446-1455.
12. Brunel P, Lefevre T, Darremont O, Louvard Y. Provisional T stenting and kissing balloon in the treatment of coronary bifurcation lesions: Results of the French multicenter "TULIPE" study. Catheter Cardiovasc Interv 2006;68:67-73.
13. Hoye A, Iakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the crush technique. Predictors of adverse outcome. J Am Coll Cardiol 2006;47:1949-1958.
14. Louvard Y, Lefevre T, Morice MC. Percutaneous coronary intervention for bifurcation coronary disease. Heart 2004;90:713-722.
15. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study). J Am Coll Cardiol 2002;40:1935-1942.
16. Ribichini F, Tomai F, Ferrero V, et al. Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD Study. Eurointervention 2005;2:173-180.
17. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: Two stents versus one stent: Immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-1151.
18. Al Suwaidi J, Berger PB, Rihal CS. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:929-936.
19. Ellis SG, Popma JJ, Lasala JM, et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Analysis from the Taxus-IV trial. J Am Coll Cardiol 2005;45:1193-1200.
20. Pepine CJ, Hirshfeld JW, Macdonald RG, et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753-1761.
21. Lee CW, Chae J, Lim H, et al. Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation. Am Heart J 1999;138:60-63.
22. Stone GW, Rutherford BD, McConahay DR, et al. A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 1989;18:227-231.
23. Gaspardone A, Versaci F, Tomai F, et al. C-reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents. Am J Cardiol 2006;97:1311-1316.
24. Ribichini F, Tomai F, Paloscia L, et al. for the DESIRE investigators. Steroid-eluting stents in patients with acute coronary syndromes. The DESIRE: Dexamethasone Eluting Stent Italian REgistry. Heart 2006 Sept 27; (Epub ahead of print).
25. MacDonald RG, Panush RS, Pepine CJ. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.AmJ Cardiol 1987;60:56B-60B.
26. Fukuda D, Shimada K, Tanaka A, et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43:18-23.
27. Frey FJ, Ruegsegger MK, Frey BM. The dose-dependent systemic availability of prednisone: One reason for the reduced biological effect of alternate-day prednisone. Br J Clin Pharmacol 1986;21:193-199.